Quantcast

Latest Clostridium Stories

2014-09-07 08:20:25

ROCKVILLE, Md., Sept. 7, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today preclinical data that further validate the Company's novel approach to preventing Clostridium difficile (C. difficile). The U.S. Centers for Disease Control has identified C. difficile as an "urgent public health threat," and it...

Research Sniffs Out Smell Of Disease In Feces
2014-09-02 03:10:38

University of Leicester A fast-sensitive "electronic-nose" for sniffing the highly infectious bacteria C. diff, that causes diarrhea, temperature and stomach cramps, has been developed by a team at the University of Leicester. Using a mass spectrometer, the research team has demonstrated that it is possible to identify the unique 'smell' of C. diff which would lead to rapid diagnosis of the condition. What is more, the Leicester team say it could be possible to identify different...

2014-09-02 08:29:18

-- Company Completes Final Preclinical Toxicology Study and Prepares to File Investigational New Drug (IND) in 2H 2014 -- ROCKVILLE, Md., Sept. 2, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today positive results from its final preclinical toxicology study of SYN-004. Per U.S. Food and Drug Administration (FDA)...

2014-08-26 08:30:16

ROCKVILLE, Md., Aug. 26, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile), will be presented at the Infectious Disease Week (IDWeek 2014(TM)) held by...

2014-05-08 20:24:35

Company launches video to help raise awareness of the brand's history and impact on patients IRVINE, Calif., May 8, 2014 /PRNewswire/ -- Allergan, Inc. (NYSE: AGN) today announced the launch of a video recognizing the physician pioneers and patient communities who contributed to the development of BOTOX(®) (onabotulinumtoxinA), one of the most recognized pharmaceutical brands in the United States. The video kicks off a year-long campaign to commemorate the 25(th) anniversary of the first...

2014-04-14 12:36:39

OTTAWA, April 14, 2014 /CNW/ - Issue: Many Sham el-Nessim celebrations include a traditional family meal. Certain salted fish products like fesikh, a traditional dish in the Egyptian community, represent an increased risk of botulism because of the way they are prepared. The fish used to make these salted fish dishes are not gutted before the ripening and salting process. This provides an opportunity for Clostridium botulinum bacteria that may be in the gut of the fish to grow...

2014-03-19 08:29:40

Novel Agents Selectively Targeting an Intestinal Pathogen and Increasing Threat to Human and Animal Health SOUTH SAN FRANCISCO, March 19, 2014 /PRNewswire/ -- AvidBiotics Corp., a privately held biotechnology company, today announced that it has received from the U.S. Patent and Trademark Office an issued patent covering its potent bactericidal proteins that selectively target and kill Clostridium difficile. The AvidBiotics' agents, a type of bacteriocin termed a "diffocin," are...

2014-02-16 23:00:46

Transparency Market Research Report added "Clostridium Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its database. Browse full report: http://www.transparencymarketresearch.com/clostridium-diagnostics-market.html. Albany, New York (PRWEB) February 16, 2014 Clostridium is a gram-positive bacteria which belongs to phylum Firmicutes, it’s an obligate anaerobe capable of producing endospores. Clostridium botulinium,...

2014-02-14 23:22:11

MarketResearchReports.Biz announces addition of new report “Global IT Business Confidence Research Report 2014” to its database. Visit: http://www.marketresearchreports.biz/analysis/187544. Albany, NY (PRWEB) February 14, 2014 IT Business Confidence Report Q1 2014 Product Synopsis “IT Business Confidence Report Q1 2014” is a new report by Kable that analyzes IT industry executives' views on the global economy, expectations of customer confidence, supplier prices, key business...

2013-12-04 16:01:15

Infants and toddlers frequently carry toxigenic Clostridium difficile, usually with no harm to themselves, but can serve as a reservoir and spread the bacteria to adults in whom it can cause severe disease, according to a study by a team of Swedish researchers published ahead of print in the Journal of Clinical Microbiology. In the study, which involved following 42 children from birth to 1 ½ or 3 years, the investigators found that C. difficile strains persisted for more than six months...


Latest Clostridium Reference Libraries

0_d6572564d3305dc462f4641398789e11
2011-04-15 13:32:47

Clostridium botulinum is a gram-positive, rod-shaped bacterium that produces neurotoxins, known as botulinum neurotoxins types A-G, that cause the flaccid muscular paralysis seen in botulism. It is the main paralytic agent in botox and is commonly found in soil. It is also an obligate anaerobe, meaning oxygen is poisonous to the cells. Superoxide dismutase helps C. botulinum tolerate traces of oxygen. It was first recognized and isolated in 1895 by Emile van Ermengem. Subsequent outbreaks...

More Articles (1 articles) »
Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related